Gilead Sciences, US government settle patent case over HIV prevention drugs
By Blake Brittain (Reuters) - Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV ...
Read moreDetailsTag: Gilead Sciences
Gilead, LEO Pharma partner to develop programs for inflammatory diseases
(Reuters) - Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs ...
Read moreDetails
